A Fast-Acting Pill Received Approval for Postpartum Depression-Is It a Game Changer?

JAMA. 2023 Sep 12;330(10):902-904. doi: 10.1001/jama.2023.16499.
No abstract available

Plain language summary

This Medical News article discusses zuranolone, the first pill approved for postpartum depression.

MeSH terms

  • Administration, Oral
  • Antidepressive Agents* / administration & dosage
  • Antidepressive Agents* / therapeutic use
  • Depression, Postpartum* / drug therapy
  • Drug Approval*
  • Female
  • Humans
  • United States

Substances

  • Antidepressive Agents